Jury Hands Down a Verdict in Prevagen Deceptive Marketing Case
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
August 2017: A federal judge granted final approval of the settlement agreement.
April 2017: A federal judge preliminarily approved a settlement of a false advertising lawsuit against Similasan Corporation. The complaint, which was originally filed in 2012, alleges that the company’s homeopathic products – including Stress & Tension Relief, Sleeplessness Relief, and Sinus Relief – are deceptively labeled because they do not work as advertised. According to the settlement terms, class members with proof of purchase may receive a refund (estimated to be at least $3.50) for each product purchased, while class members without proof of purchase are limited to one refund. In addition, the company agreed to make changes to product labels, including providing more information to future purchasers. (Allen et al v. Similasan Corp., Case No. 12-cv-376, S. D. CA.)
For more information about the marketing of homeopathic products and TINA.org’s coverage of the issue, click here.
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Regulators have a beef with company’s climate pledge.
Consumers need to be wary of undisclosed incentivized reviews.
Why TINA.org supports FTC’s proposed changes to COPPA Rule but pushes for more.
FTC alleges company pressures consumers into overpaying for its tax filing software.